Epidemiological Peculiarities of New Coronavirus Infection (COVID-2019). Communication 2: Peculiarities of epidemic process development in conjunction with performed anti-epidemic measures around the world and in the Russian Federation
https://doi.org/10.21055/0370-1069-2020-2-6-12
Abstract
The review presents the analysis of the data on the spread of COVID-19 around the world and in Russia available as of June 15, 2020. Dynamics and geographical dissemination of COVID-19 in the Russian Federation is considered. The structure of incidence by gender and age is presented. Assessment of the key epidemiological parameters (morbidity rates and lethality) is provided. The effectiveness of the response measures conducted to control COVID-19 is discussed.
About the Authors
V. V. Kutyrev
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
46, Universitetskaya St., Saratov, 410005
A. Yu. Popova
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare;
Russian Medical Academy of Continuing Professional Education
Russian Federation
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994;
2/1, Barrikadnaya St., Moscow, 125993
V. Yu. Smolensky
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
E. B. Ezhlova
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
Yu. V. Demina
Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
Russian Federation
18, Bld. 5 and 7, Vadkovsky Pereulok, Moscow, 127994
V. A. Safronov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005
Russian Federation
46, Universitetskaya St., Saratov, 410005
I. G. Karnaukhov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005
Russian Federation
46, Universitetskaya St., Saratov, 410005
A. V. Ivanova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005
Russian Federation
46, Universitetskaya St., Saratov, 410005
S. A. Shcherbakova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
46, Universitetskaya St., Saratov, 410005
Russian Federation
46, Universitetskaya St., Saratov, 410005
References
1. Novel Coronavirus – China. (Cited 15 June 2020). [Internet]. Available from: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/.
2. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). (Cited 15 June 2020). [Internet]. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
3. Federal Service for Surveillance in the Sphere of Consumers Rights Protection and Human Welfare. COVID-19 Coronavirus. Information for citizens. (Cited 15 June 2020). [Internet]. Available from: https://www.rospotrebnadzor.ru/about/info/news_time/news_details.php?ELEMENT_ID=13566.
4. Estimating the infection fatality rate among symptomatic COVID-19 cases in the United States. (Cited 15 June 2020). [Internet]. Available from: https://www.healthaffairs.org/doi/pdf/10.1377/hlthaff.2020.00455.
5. CEBM. Global Covid-19 Case Fatality Rates. (Cited 15 June 2020). [Internet]. Available from: https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/.
6. Lombardi A., Consonni D., Carugno M., Bozzi G., Mangioni D., Muscatello A., Castelli V., Palomba E., Cantщ A.P. Ceriotti F., Tiso B., Pesatori A.C., Riboldi L., Bandera A., Gori A. Characteristics of 1,573 healthcare workers who underwent nasopharyngeal swab for SARS-CoV-2 in Milano, Lombardy, Italy. (Cited 15 June 2020). [Internet]. Available from: https://www.medrxiv.org/content/10.1101/2020.05.07.20094276v1.
7. Takita M., Matsumura T., Yamamoto K., Yamashita E., Hosoda K., Hamaki T., Kusumi E. Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo. (Cited 15 June 2020). [Internet]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.29.20085449v1.
8. Kutyrev V.V., Popova A.Yu., Smolensky V.Yu., Ezhlova E.B., Demina Y.V., Safronov V.A., Karnaukhov I.G., Ivanova A.V., Shcherbakova S.A. Epidemiological Features of New Coronavirus Infection (COVID-19). Communication 1: Modes of Implementation of Preventive and Anti-Epidemic Measures. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2020; (1):6–13. DOI: 10.21055/0370-1069-2020-1-6-13.
9. Zhongwei Huang, Jianping Huang, Qianqing Gu, Pengyue Du, Hongbin Liang, Qing Dong Optimal temperature zone for the dispersal of COVID-19. (Cited 15 June 2020). [Internet]. Available from: https://www.sciencedirect.com/science/article/pii/S0048969720330047.
10. de Lusignan S., Dorward J., Correa A., Jones N., Akinyemi O., Amirthalingam G., Andrews N., Byford R., Dabrera G., Elliot A., Ellis J., Ferreira F., Bernal J.L., Okusi C., Ramsay M., Sherlock J., Smith G., Williams J., Howsam G., Zambon M., Joy M., Hobbs R. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. (Cited 15 June 2020). [Internet]. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30371-6/fulltext.
11. Coelho M.T.P., Rodrigues J.F.M., Medina A.M., Scalco P., Terribile L.C., Bruno Vilela B., Diniz-Filho J.A.F., Dobrovolski R. Exponential phase of covid19 expansion is driven by airport connections. (Cited 15 June 2020). [Internet]. Available from: https://www.medrxiv.org/content/10.1101/2020.04.02.20050773v2.
12. Zou J., Bretin A., Gewirtz A. Antibodies to SARS/CoV-2 in arbitrarily-selected Atlanta residents. (Cited 15 June 2020). [Internet]. Available from: https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1.
Review
For citations:
Kutyrev V.V., Popova A.Yu., Smolensky V.Yu., Ezhlova E.B., Demina Yu.V., Safronov V.A., Karnaukhov I.G., Ivanova A.V., Shcherbakova S.A. Epidemiological Peculiarities of New Coronavirus Infection (COVID-2019). Communication 2: Peculiarities of epidemic process development in conjunction with performed anti-epidemic measures around the world and in the Russian Federation. Problems of Particularly Dangerous Infections. 2020;(2):6-12. (In Russ.) https://doi.org/10.21055/0370-1069-2020-2-6-12
Views:
2762
Email this article 